Xiongwen Zhang

7PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2025
Ruxolitinib alleviated muscle atrophy in cancer cachexia by inhibiting IL-6/JAK/STAT3 signaling pathway in mice.

Cong Li, Xiaofan Gu, Zixia Zhu

|Jul 13, 2023
Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.

Ruiqin Zhang, Qiang Shen, Yueping Wang

|Sep 10, 2022
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.

Meng Fan, Xiaofan Gu, Wanli Zhang

|Apr 05, 2022
GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway.

Wanli Zhang, Weikuan Sun, Xiaofan Gu

|Sep 29, 2021
Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome.

Lixing Feng, Wanli Zhang, Qiang Shen

Pageof 2